BioNTech will share updated clinical data for new immunotherapy candidates at the ASCO Annual Meeting 2024.

MAINZ, Germany, May 21, 2024 BioNTech SE (Nasdaq: BNTX, BioNTech or the Company ) will present clinical trial data for selected programs from the Company’s diversified immuno-oncology pipeline…

Read More: https://www.globenewswire.com/news-release/2024/05/21/2885408/0/en/BioNTech-to-Present-Clinical-Data-Updates-for-Next-Generation-Immunotherapy-Candidates-at-the-ASCO-Annual-Meeting-2024.html